Kirsten B. Burdett

Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial

Jawad Fares, Atique U. Ahmed, Ilya V. Ulasov et al. · The Lancet Oncology · 2021 · 191 citations · Full text

Neuro-oncology, Glioma, Neural Stem Cell +8

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Víctor A. Arrieta, Andrew Chen, J. Robert Kane et al. · Nature Cancer · 2021 · 111 citations · Full text

Neuro-oncology, Glioma, Erk1/2 Phosphorylation +8

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Angeles Alvarez Secord, Kirsten B. Burdett, Kouros Owzar et al. · Clinical Cancer Research · 2020 · 55 citations · Full text

Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors

Michael Drumm, Wenxia Wang, Thomas Sears et al. · Journal of Clinical Investigation · 2023 · 45 citations · Full text

Ribosomal protein S11 influences glioma response to TOP2 poisons

Chidiebere U. Awah, Li Chen, Mukesh Bansal et al. · Oncogene · 2020 · 31 citations · Full text

Neuro-oncology, Tumor Biology, Glioma +7